JAMA Author Interviews podcast

Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant

0:00
11:25
Recuar 15 segundos
Avançar 15 segundos

Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS.

Related Content:

Mais episódios de "JAMA Author Interviews"